Bayesian estimation of the proportion of treatment effect captured by a surrogate marker.
- 19 February 2002
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 21 (6) , 811-834
- https://doi.org/10.1002/sim.1057
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trialThe Lancet, 1999
- Virologic and Immunologic Response to Nucleoside Reverse‐Transcriptase Inhibitor Therapy among Human Immunodeficiency Virus–Infected Infants and ChildrenThe Journal of Infectious Diseases, 1999
- Correlation between plasma transforming growth factor-β1 and second primary breast cancer in a chemoprevention trialEuropean Journal Of Cancer, 1998
- ESTIMATING THE PROPORTION OF TREATMENT EFFECT EXPLAINED BY A SURROGATE MARKERStatistics in Medicine, 1997
- Evaluating the Validity of Probing Attachment Loss as a Surrogate for Tooth Mortality in a Clinical Trial on the ElderlyJournal of Dental Research, 1997
- Changes in Plasma HIV-1 RNA and CD4+ Lymphocyte Counts and the Risk of Progression to AIDSNew England Journal of Medicine, 1996
- Some approaches to the analysis of recurrent event dataStatistical Methods in Medical Research, 1994
- Statistical validation of intermediate endpoints for chronic diseasesStatistics in Medicine, 1992
- Regression Analysis of Multivariate Incomplete Failure Time Data by Modeling Marginal DistributionsJournal of the American Statistical Association, 1989
- Cox's Regression Model for Counting Processes: A Large Sample StudyThe Annals of Statistics, 1982